San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Sharp's Chief Medical Officer Appointed to HQI Board

Sharp Chula Vista Medical Center’s chief medical officer has been appointed to a board that helps a number of state and regional groups improve industry performance and foster innovation.

Tease photo

Illumina, IBM to Deploy Watson to Take on Cancer Treatments

Illumina Inc. kicked off the J.P. Morgan Healthcare Conference with a bang Monday morning when the company announced a partnership with IBM Watson that could revolutionize cancer care.

Tease photo

Mast Therapeutics Merges With Austin-Based Biotech

Following a major clinical trial flop, San Diego’s public biotech Mast Therapeutics Inc. will merge with Austin, Texas-based Savara Inc.

Innovation Fund Makes $500,000 Investment in AristaMD

San Diego digital health company AristaMD has received a $500,000 investment from the Philadelphia College of Osteopathic Medicine’s Primary Care Innovation Fund.

Tease photo

7 Things to Know About GRAIL’s Spinout from Illumina

Illumina Inc.’s much-touted cancer test venture, GRAIL, is spinning out from its San Diego-based parent and raising $1 billion to develop its technology.

Versant Ventures Announces Leader for New Fund's Investments in San Diego, Bay Area

Versant Ventures, a global health care investment firm, announced Thursday it has appointed Clare Ozawa to lead investments in San Diego and in the Bay Area in preparation for the launch of its new $400 million fund.

Skin Care Biotech Closes $1.5 Million Funding Round

MatriSys Bioscience, a small biotechnology firm in La Jolla, has landed $1.5 million in a round led by professional angel investing group Tech Coast Angels (TCA).

Tease photo

Tina Nova’s Co. Attracts Seed Money, Key Collaboration with Pfizer Inc.

Ex-Illumina executive Tina Nova’s latest venture has landed $8.2 million in seed money and a collaboration with drug giant Pfizer Inc.

Tease photo

Arena Weighs Advantages, Decides to Deal Belviq to Eisai

San Diego drugmaker Arena Pharmaceuticals Inc. is unloading its only FDA-approved drug, the anti-obesity pill Belviq, to its longtime Japanese partner, Eisai Co. Ltd.

Tease photo

C-Suite Shuffle at Amplyx Pharmaceuticals

Mike Grey, a veteran of the biotech industry, is stepping aside from his role at Amplyx Pharmaceuticals Inc. and handing the reins to Ciara Kennedy, the company’s chief operating officer.

Tease photo

Mary Naggs Joins Executive Team at Apricus Biosciences

Local drugmaker Apricus Biosciences Inc. has promoted its internal associate general counsel, Mary Naggs, to the company’s executive team.

Tease photo

Dr. Michael Sise Named Chief of Staff at Scripps

Vascular surgeon Dr. Michael Sise has been elected chief of staff by doctors at Scripps Mercy Hospital’s Hillcrest and Chula Vista campuses.

Tease photo

Arena Pharmaceuticals Bails on Its Weight-Loss Drug

San Diego drugmaker Arena Pharmaceuticals Inc. is unloading its only FDA-approved drug, the anti-obesity pill Belviq, to its longtime Japanese partner, Eisai Co. Ltd.

Tease photo

Genomics Pioneer Craig Venter Relinquishing CEO Role at HLI

Local genomics legend J. Craig Venter is stepping aside from his post as chief executive officer of Human Longevity Inc., turning over the helm to former GE Healthcare executive Cynthia Collins.

Poseida Therapeutics Hires Regulatory Affairs Expert

Poseida Therapeutics Inc., a local firm using gene editing to develop medicines, announced that Debra Gessner, an expert in regulatory affairs, will join the company’s executive team.